Real-time enrollment status for this chronic migraine clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT04616326 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Chronic Migraine |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT04616326 is currently active_not_recruiting participants. This clinical trial study for chronic migraine is not currently accepting new participants at 46 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04616326 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04616326 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.